PH16567A - Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods - Google Patents

Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods

Info

Publication number
PH16567A
PH16567A PH24603A PH24603A PH16567A PH 16567 A PH16567 A PH 16567A PH 24603 A PH24603 A PH 24603A PH 24603 A PH24603 A PH 24603A PH 16567 A PH16567 A PH 16567A
Authority
PH
Philippines
Prior art keywords
antibody
suppressor
cells
methods
cell line
Prior art date
Application number
PH24603A
Other languages
English (en)
Inventor
Chung-Shu Kong Patrick
Goldstein Gideon
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH16567(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of PH16567A publication Critical patent/PH16567A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH24603A 1979-09-18 1980-09-18 Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods PH16567A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7664279A 1979-09-18 1979-09-18
US06/082,515 US4364932A (en) 1979-09-18 1979-10-09 Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same

Publications (1)

Publication Number Publication Date
PH16567A true PH16567A (en) 1983-11-18

Family

ID=26758322

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24603A PH16567A (en) 1979-09-18 1980-09-18 Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods

Country Status (19)

Country Link
US (1) US4364932A (fr)
EP (1) EP0025722B2 (fr)
AU (1) AU537806B2 (fr)
CA (1) CA1170593A (fr)
DE (2) DE3070669D1 (fr)
DK (1) DK154566C (fr)
ES (1) ES495165A0 (fr)
FI (1) FI75364C (fr)
GR (1) GR70286B (fr)
HK (1) HK23986A (fr)
IE (1) IE50534B1 (fr)
IL (1) IL61063A (fr)
MY (1) MY8600515A (fr)
NO (1) NO159884C (fr)
NZ (1) NZ194982A (fr)
PH (1) PH16567A (fr)
PT (1) PT71814B (fr)
SG (1) SG6386G (fr)
YU (1) YU44411B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4524025A (en) * 1982-06-30 1985-06-18 E. I. Du Pont De Nemours And Company Hybridoma cell lines and monoclonal antibodies to theophylline
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
WO1987006610A1 (fr) * 1986-04-28 1987-11-05 Endotronics, Inc. Procede de culture de leucocytes
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
WO1999025734A2 (fr) * 1997-11-13 1999-05-27 Schering Corporation APPAUVRISSEMENT DE LA CELLULE Th2, COMPOSITIONS ET METHODES EN RAPPORT
AU1539699A (en) * 1997-11-24 1999-06-15 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
DE3070669D1 (en) 1985-06-27
HK23986A (en) 1986-04-11
EP0025722A2 (fr) 1981-03-25
IL61063A0 (en) 1980-11-30
NO159884B (no) 1988-11-07
EP0025722B1 (fr) 1985-05-22
ES8200559A1 (es) 1981-11-16
PT71814A (en) 1980-10-01
EP0025722A3 (en) 1981-11-04
GR70286B (fr) 1982-09-03
FI802917A (fi) 1981-03-19
YU44411B (en) 1990-08-31
NZ194982A (en) 1983-02-15
IE50534B1 (en) 1986-05-14
DK394880A (da) 1981-03-19
AU537806B2 (en) 1984-07-12
NO802751L (no) 1981-03-19
PT71814B (en) 1982-03-26
ES495165A0 (es) 1981-11-16
FI75364B (fi) 1988-02-29
IE801944L (en) 1981-03-18
AU6247680A (en) 1981-04-09
DK154566B (da) 1988-11-28
IL61063A (en) 1984-04-30
CA1170593A (fr) 1984-07-10
NO159884C (no) 1989-02-15
FI75364C (fi) 1988-06-09
EP0025722B2 (fr) 1999-04-14
SG6386G (en) 1986-11-21
YU239280A (en) 1984-04-30
DK154566C (da) 1989-04-17
MY8600515A (en) 1986-12-31
US4364932A (en) 1982-12-21
DE25722T1 (de) 1984-07-19

Similar Documents

Publication Publication Date Title
PH16567A (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells,antibody and methods
IL76142A (en) Monoclonal antibody specific to a human carcinoma tumor-associated antigen kc-4,hybrid cell lines producing the same,pharmaceutical compositions containing them and methods for the use thereof
MY8600514A (en) Monoclonal-antibody-producing hybird cell line, antibody and method of preparing it, therepeutic composition containing it and its diagnostic and therapeutic uses
GB2039948B (en) Cell lines
CA1262238C (fr) Anticorps monoclonaux humains contre les toxines bacteriennes
IL87535A (en) Hybrid cell lines producing kc-57 monoclonal antibodies specific to hiv core antigens
EP0178891A3 (fr) Lignées de cellules humaines-humaines produisant des anticorps contre des déterminants antigéniques de cellules cancéreuses
PT72301A (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
PH14144A (en) Process for culturing cells
ZA805743B (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and supressor t cells, antibody, and methods
HRP940809B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody and methods
IL75793A0 (en) Monoclonal antibodies against human ifn-ypsilon,their preparation and their use and hybrid cell lines producing these antibodies
IL86678A0 (en) Hybrid cell line and monoclonal antibodies
HRP940822B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human supressor t cells, antibody and methods
HRP940786B1 (en) Hybrid cell line for production of monoclonal antibody for human cytotoxic and supressor t cells, antibody and process
HRP940824B1 (en) Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods
DE2963410D1 (en) Process for obtaining murine immunglobulin-e antibodies, hybrid cell lines used in the process and the process for preparing them, application of the immunglobulin-e antibodies so obtained
HRP940808B1 (en) Hybrid cell line for producing monoclonal antibody to helper t cells, antibody and method of preparation thereof
HRP940830B1 (en) Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods
HRP940790B1 (en) Hybrid cell line for producing monoclonal antibody to a human thymocyte antigen, antibody and method of preparation thereof
HRP940823B1 (en) Hybrid cell line for producing monoclonal antibody to a human early thymocite antigen, antibody and method of preparation of this antibody
JPS55110785A (en) Hybrid method for obtaining hydrogen
PH20477A (en) Nybrid cell line for producing monoclonal antibody to a human monocyte antigen,antibody and methods
ZA771910B (en) Process for culturing cells
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 13